Heavy 13 departments issued!Solve the problem of low incidence and high mortality of cancer in China

Mondo Health Updated on 2024-01-29

Cancer is one of the deadliest "health killers" in Chinese. According to the 2022 China Health Statistical Yearbook, the number of deaths in China reached 10.46 million in 2021, and the number of cancer deaths was as high as 228310,000, ranking second among Chinese deaths in 2021.

In order to further improve the cancer prevention and control system, enhance the ability of cancer screening, early diagnosis and early treatment, and reduce cancer incidence and mortality.

The National Health Commission, the National Health Commission and 13 other departments jointly issued the "Healthy China Action - Cancer Prevention and Control Action Implementation Plan (2023-2030)" (hereinafter referred to as the "Plan").

The plan proposes specific measures to strengthen the dissemination of core knowledge of cancer prevention and control, improve the cancer prevention and control network at the national-provincial-municipal-county level, provide technical guidance for cancers with high incidence and relatively mature screening methods, and standardize cancer diagnosis and treatment and the construction of cancer-related disciplines in terms of operation and medication.

Cancer prevention and control

On the one hand, the proposal of the plan clarifies the country's attitude towards cancer prevention and control. Take 2023 as the node to give a number of quantitative indicators, and give market space guidance.

On the other hand, the "Programme" on the additionCancer chemoradiotherapy, imaging, pathology, prevention, nursing, hospice care, and pediatric oncologyand other fields of professional enrollment plans and professional talent training.

We will transform talent advantages into high-quality development momentum, accelerate major scientific and technological research, transform innovation achievements, and further promote the development of the cancer industry. Tumor prevention, diagnosis and treatment, nursing and other fields are expected to benefit.

Earlier this year, cancer data published by the American Cancer Society in CA showed that cancer mortality in the United States has been declining over the past two decades.

Source: Debang Securities.

Excluding the influencing factors of age structure,The incidence of cancer in China is lower than in the United States, but the mortality rate is higher than in the United States, revealing the difference in the effect of cancer**.

The "five-year survival rate" is often used as an evaluation index for cancer**, and the probability of cancer patients surviving for more than 5 years after surgery** is considered to be 90%.

Data shows that the average five-year survival rate for cancer in the United States is 66%, while in China it is 309%, one of the reasons for this gap is the difference in performance in the field of early screening.

In fact, China has been in the field of cancer screening since 2017. In January, the "13th Five-Year Plan for Health and Wellness" was released, which clearly pointed out that the project of early diagnosis and early treatment of cancer in rural high-incidence areas, urban areas and quasi-river basin areas will be carried out, and early screening of cancer including esophageal cancer, kidney cancer and colorectal cancer will be carried out for high-risk groups of cancer in the project area.

In December of the following year, the National Health Commission issued the Notice on Printing and Distributing the Diagnosis and Treatment Standards for 18 Tumors Including Primary Lung Cancer (2018 Edition), which stipulates the diagnosis and treatment of 18 types of cancer, including primary lung cancer, thyroid cancer, esophageal cancer, gastric cancer, pancreatic cancer, and breast cancer.

In 2020, the Ministry of Science and Technology of the People's Republic of China will build a high-sensitivity, high-specific, efficient and economical early diagnosis technology system for malignant tumors in the "R&D and Application Project of Early Screening and Early Diagnosis Technology for High-Incidence Malignant Tumors", and develop screening and early diagnosis kits with completely independent intellectual property rights for lung cancer and digestive tract cancer in China. Based on this, early cancer screening products have been promoted to escort the health of more Chinese people.

Analysis of the seven major areas of the "Implementation Plan".

(1) Chemotherapy and radiotherapy

Original: 1Appropriately increase the enrollment plan and professional talent training in the fields of cancer radiotherapy and chemotherapy, imaging, pathology, prevention, nursing, hospice care, and pediatric oncology. 2.Strengthen the scientific and technological demonstration of advanced diagnosis and treatment technologies related to cancer, clinical guidelines and norms, screening programs, etc., and accelerate the promotion of the universalization of scientific and technological innovation services.

Chemoradiotherapy is one of the main methods of cancer**. Sullivan data shows that the domestic tumor radiotherapy market size is 13With a growth rate of 7%, compared with developed countries, the penetration rate of radiotherapy in China is low, and the acceptance of patients is weak.

Professional enrollment plans and talent training are necessary in the long run. At the same time, it also shows that China attaches great importance to cancer patients and the targeted training of talents.

Strengthening cancer-related advanced diagnosis and treatment technologies and guidelines has also made the field of cancer more standardized and improved the whole process of diagnosis and treatment experience for patients.

(2) Image:

Original: Appropriately increase the professional enrollment plan and professional talent training in the fields of cancer radiotherapy and chemotherapy, imaging, pathology, prevention, nursing, hospice care, and pediatric tumors.

Imaging is the main means of cancer diagnosis, and ultrasound, CT, MRI, and radionuclide scanning are of great significance for early detection of cancer, diagnosis of cancer cell metastasis, and preoperative evaluation. The cultivation of imaging talents will not only improve the evaluation of the industry, but also upgrade the quality of talents.

(3) Pathology:

Original text: The early diagnosis rate of key cancers in high-incidence areas has continued to increase, the screening rate of cervical cancer among women of appropriate age has reached 70%, and the screening coverage rate of breast cancer has gradually increased.

Pathological diagnosis has gradually become a new standard for early cancer screening, and the rapid development of the pathological diagnosis industry depends on the improvement of tumor incidence and the support of national cancer early screening policies.

However, due to the characteristics of complex pathological diagnosis process, low degree of automation, long manual investment time, and large dependence on doctors, there is a serious shortage of pathologists at present.

With the support of policies such as the Implementation Plan and the Thousand Counties Project, the market scale of the pathology industry is expected to expand, and pathological diagnosis will be more automated, standardized, digital and intelligent.

(4) Prevention:

Original text: In view of the high incidence of cancer, the early stage, cost-effectiveness, and simple and easy screening methods in the region, all localities have gradually expanded the coverage of screening, early diagnosis and early treatment. Ongoing organizational screening in high-risk areas and in high-risk populations.

In recent years, the coverage of early cancer diagnosis in China has continued to improve, and many provinces and cities such as Shanghai, Zhejiang, Tianjin, and Jiangsu have included key cancer screening in their livelihood projects and provided it to residents free of charge.

As of 2022, the early diagnosis rate of key cancer types in high-incidence areas in China has reached more than 55%.

Physical examination institutions and ICL institutions are also increasing the provision of special cancer early screening projects, and at the same time optimizing the testing items, such as replacing gastroscopy with capsule gastroscopy and non-invasive screening of blood and fecal DNA instead of colonoscopy, so as to further improve the penetration rate of early screening.

(5) Nursing, hospice care:

Original: Cancer hospitals with strong professional skills are encouraged to carry out technical assistance in areas with a large outflow of cancer patients, and improve the overall cancer prevention and control capacity in areas with insufficient resources through the export of talents, technology, brand, management, etc. Qualified secondary and above hospitals have set up oncology departments, which can carry out cancer screening and general diagnosis and treatment of common multiple cancers. Further strengthen the construction of various forms of medical alliances such as cancer-related specialty alliances.

The three-year implementation plan from 2019 to 2022 has achieved the following results: the national, provincial, and municipal comprehensive cancer prevention and control network has been basically completed, especially the expansion of high-quality cancer prevention and control resources, and the reasonable and balanced distribution between regions.

As a supplement to public cancer medical services, private oncology specialties play an important role in reducing the imbalance in the supply of regional high-quality oncology medical services, and with the promotion of further deepening of screening, the demand for diagnosis and treatment in various regions will also increase.

(6) Children's tumors:

Original: Appropriately increase the professional enrollment plan and professional talent training in the fields of cancer radiotherapy and chemotherapy, imaging, pathology, prevention, nursing, hospice care, and pediatric tumors.

The incidence and mortality of malignant tumors in China are positively correlated with age, and childhood tumors are rare in nature and more sensitive to traditional chemoradiotherapy.

Behind the lack of drugs for pediatric oncology is the difficulty of pediatric clinical research, which improved in 2019.

Since 2019, the National Health Commission, the Food and Drug Administration, the National Health Insurance Administration and other departments have withdrawn a number of favorable policies for pediatric oncology drugs, mainly including simplifying clinical trials, shortening the registration and approval process to reduce development costs, and accelerating the marketing process, and pediatric oncology drugs are expected to achieve breakthroughs.

(7) Traditional Chinese medicine:

Original text: Strengthen the construction of the oncology department of the Chinese medicine hospital, and support the general hospital and the cancer specialized hospital to provide cancer traditional Chinese medicine diagnosis and treatment servicesThe prevention and treatment of cancer with traditional Chinese medicine should be included in the service scope of primary medical institutions. Cultivating professionals in traditional Chinese medicine for cancer prevention and treatment. In the multidisciplinary diagnosis and treatment of tumors, we should standardize the development of traditional Chinese medicine and give full play to the unique role and advantages of traditional Chinese medicine.

In traditional tumors, most of them are controlled by surgery, chemoradiotherapy, immunology, and targeting. However, traditional Chinese medicine is also an indispensable tool in tumors**.

As early as more than 3,500 years ago in the Yin and Zhou dynasties, the name of "tumor" has been recorded on the oracle bone inscription of Yinxu, and the word "tumor" is composed of "disease prefix" and "stay", which contains the meaning of "stay and gather and do not go", which is also the earliest document of Chinese medicine to record tumors found today. The systematic understanding of cancer in Chinese medicine began with the "Yellow Emperor's Neijing".

Traditional Chinese medicine believes that tumors occur in a certain part of the body, but are related to the entire function of the body. Tumors are formed by the coalescence of blood stasis, stagnation, phlegm drinking, heat toxicity and other leading factors under certain environmental conditions.

**Methods include "Righteousness" and "Exorcism". "Fuzheng" makes the human body resistant to fight tumors by nourishing qi and blood, and "dispelling evil" uses soft and hard knots to dissolve tumor masses.

In recent years, traditional Chinese medicine has attracted much attention in the field of diseases, and the combination of traditional Chinese and Western medicine is expected to open up a new blue ocean in the field of tumors

**Info x MED App, a !! for accurate query of massive literature

Related Pages